‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
Journal of Clinical Oncology (JCO) Podcast
The Addition of Another Camptothecin Fails to Improve Outcomes in Patients With Intermediate-Risk Rhabdomyosarcoma
30
00:00:00
/ 00:10:56
30